Contract

Live attenuated influenza vaccine (2022)

  • Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

F03: Contract award notice

Notice identifier: 2022/S 000-022129

Procurement identifier (OCID): ocds-h6vhtk-035aed

Published 11 August 2022, 11:52am



Section one: Contracting authority

one.1) Name and addresses

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Nobel House, 17 Smith Square

London

SW1P 3JR

Contact

Chantal Jockel

Email

chantal.jockel@dhsc.gov.uk

Country

United Kingdom

Region code

UKI32 - Westminster

Internet address(es)

Main address

https://www.gov.uk/government/organisations/uk-health-security-agency

Buyer's address

https://www.gov.uk/government/organisations/uk-health-security-agency

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Live attenuated influenza vaccine (2022)

Reference number

CM/PHV/22/15034

two.1.2) Main CPV code

  • 33651660 - Influenza vaccines

two.1.3) Type of contract

Supplies

two.1.4) Short description

Contract for the supply of live attenuated influenza vaccine

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £1

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom
Main site or place of performance

To a location(s) in the UK to be notified to the successful bidder following contract award

two.2.4) Description of the procurement

The provision of a live attenuated influenza vaccine. Deliveries will be required over the initial term of 2 years and the contract has the option to be extended for up to an additional 24 months.

two.2.5) Award criteria

Quality criterion - Name: Quality / Weighting: N/A

Quality criterion - Name: Risk / Weighting: N/A

Cost criterion - Name: Cost / Weighting: N/A

two.2.11) Information about options

Options: Yes

Description of options

This contract has the option to be extended for up to an additional 24 months

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

Value - The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The services can be provided only by a particular economic operator for the following reason:
    • absence of competition for technical reasons

Explanation:

There is only one manufacturer of this vaccine approved for use in the UK, therefore using the negotiated procedure without prior publication is justified under Regulation 32(2)(b)(ii) of the Public Contracts Regulations 2015.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

15 July 2022

five.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

AstraZeneca UK Ltd

1 Francis Crick Avenue Cambridge Biomedical Campus

Cambridge

CB2 0AA

Country

United Kingdom

NUTS code
  • UKH1 - East Anglia
National registration number

03674842

The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £1

Total value of the contract/lot: £1


Section six. Complementary information

six.3) Additional information

The contract(s) is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.

six.4) Procedures for review

six.4.1) Review body

The High Court

Strand

London

WC2A 2LL

Email

generaloffice@administrativecourtoffice.justice.gov.uk

Country

United Kingdom

Internet address

https://www.gov.uk/courts-tribunals